🟢 MiniMed Group is trading 5% up today on raised FY2027 growth guidance

MiniMed Group is trading 4.79% up at $23.50 after September 1 earnings and raised FY2027 growth guidance.

• Revenue was $843 million in first-quarter FY2027, with 15.8% organic growth and a stronger-than-expected U.S. pump launch.
• Full-year organic-growth guidance rose to approximately 10.5% from 10%; adjusted EBITDA-margin target stayed near 16%.
• Wells Fargo raised its target to $26 from $22; shares gained 10.66% on September 1, while Healthcare rose 1.26%. [Earnings Report ID: 6a96aeebc3fd83e78c1be924]